Biotech

All Articles

2 cancer cells biotechs merge, developing worldwide impact

.OncoC4 is actually taking AcroImmune-- and its in-house professional production capabilities-- unde...

Amgen documents 1st stage 3 gain for $400M dermatitis drug

.Amgen has shared (PDF) the initial phase 3 information on its own $400 thousand chronic eczema medi...

Biogen, UCB report period 3 lupus succeed after falling short earlier test

.Biogen as well as UCB's bank on developing into stage 3 astride an unsuccessful research study hope...

Aptadir hopes brand-new RNA preventions can reverse challenging cancers

.Italian biotech Aptadir Therapeutics has launched with the pledge that its own pipe of preclinical ...

Wave surfs DMD results to regulators' doors, delivering stock up

.Wave Life Sciences has fulfilled its own target in a Duchenne muscular dystrophy (DMD) research, po...

Sanofi plucks brand new CSO from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is going back to the pharma fold, using u...

Achilles drops tissue therapy system, prepares for discharges after overlooking 'business feasibility' goals

.Achilles Therapies has actually wrecked its technique. The British biotech is actually knocking off...

Aligos proclaims phase 2 MASH win, slashing liver body fat as much as 46%

.Aligos Rehabs is proclaiming a midstage succeed in metabolic-dysfunction linked steatohepatitis (MA...

Basilea ratings $268M BARDA financing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work developing brand new antifungals has actually gotten a significant inc...

Capricor sells Europe rights to late-stage DMD treatment for $35M

.Possessing presently gathered up the united state civil rights to Capricor Rehabs' late-stage Duche...